Journal of Cancer Genetics And Biomarkers

Dr. Tom Zhang, Scientist, SinoScript LLC
Editor-in-Chief

Dr. Tom Zhang

Scientist, SinoScript LLC · United States

Editorial leadership for Journal of Cancer Genetics And Biomarkers ISSN 2572-3030

Research interests

  • Genomic Experiment Design
  • Analysis Using Ucsc Genome Browser
  • Primer-Blast. &Nbsp;Genetic/Epigenetic Analysis: 2Nd Generation Sequencing
  • Chromatin Immunoprecipitation (Chip) Seq. &Nbsp;Biochemistry Analysis: Quantity
  • Quality Analysis Of Amino Acids
  • Proteins. &Nbsp;Molecular Biology Techniques: Molecular Cloning
  • Protein Purification
  • Co-Immunoprecipitation. &Nbsp;Culturing Microbes (Viruses
  • Bacteria
  • Phage
  • Yeast)
  • Human Primary Cells
  • Cell Lines. &Nbsp;Cell
  • Tissue Imaging: Immunofluorescence Confocal Microscopy
  • Immunohistochemistry Staining. &Nbsp;Cell Functional Analysis
  • Flow Cytometry: Proliferation
  • Migration
  • Cell Cycle
  • Apoptosis
  • Viability. &Nbsp;Animal Handling: Genotyping
  • Intraperitoneal
  • Intravenous Injections
  • Blood
  • Tissue Collection. &Nbsp;Proficiency With Statistical Software: Excel
  • Spss
  • Sas
  • Graphpad Prism. &Nbsp;Knowledge Of Bioinformatics Databases: Microarray
  • Proteomics (E.g. Phosida)
  • Gsea

Biography

  • Highly motivated and independent scientist with degrees and training from top ranked institutions.
  • Specializes in cancer genetics research and has extensive experience in many different facets of this field, including cancer immunology, cancer epigenetics and cancer metabolomics.
  • Work experience beyond research includes providing biomedical research consulting, writing and reviewing highly acclaimed journals, mentoring younger scientists and laboratory management.
  • Published over a dozen articles in high-impact journals in the past five years.

Considering JCGB for your work?

This journal is guided by Dr. Tom Zhang (Scientist, SinoScript LLC) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.

Start your submission

Menu